HER 2 POSITIVE GASTRIC CANCER

Clinical trials for HER 2 POSITIVE GASTRIC CANCER explained in plain language.

Never miss a new study

Get alerted when new HER 2 POSITIVE GASTRIC CANCER trials appear

Sign up with your email to follow new studies for HER 2 POSITIVE GASTRIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Experimental stomach cancer combo trial halted after only 2 patients

Disease control Terminated

This early-stage study tested a new drug called AUR103 combined with standard treatments (trastuzumab and chemotherapy) for people with advanced HER2-positive stomach or gastroesophageal junction cancer. The goal was to see if the combination was safe and effective. However, the …

Matched conditions: HER 2 POSITIVE GASTRIC CANCER

Phase: PHASE1, PHASE2 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control

Last updated May 13, 2026 16:01 UTC

HER 2 POSITIVE GASTRIC CANCER

Get alerted when new HER 2 POSITIVE GASTRIC CANCER trials appear

Experimental stomach cancer combo trial halted after only 2 patients